Managers / Q1 2023 · view latest →
Cahill Wealth Management, LLC
CIK 0001927960 · 5831 OAKLAND DRIVE, PORTAGE, MI, 49024 · 269-321-6600
Summary
Cahill Wealth Management, LLC reported $135M in U.S.-listed holdings across 47 positions for Q1 2023.
The portfolio is heavily concentrated: IVV alone accounts for 51.1% of reported value.
Compared with Q4 2022, the fund opened 1 new position and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 84.8% · $115M
- Common Stock · 14.9% · $20M
- ADR · 0.2% · $241,864
- Other · 0.1% · $134,417
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| EXPION360 INC | NEW | +27.8K | 27.8K | +$134,417 | $134,417 |
| TRANSCODE THERAPEUTICS INC | SOLD OUT | −47.1K | 0 | −$22,946 | $0 |
| DFAUDIMENSIONAL ETF TRUST | TRIMMED | −9.0K | 21.7K | −$274,842 | $623,732 |
| VRNAVERONA PHARMA PLC | ADDED | +2.3K | 12.0K | +$24,049 | $241,864 |
| AMZNAMAZON COM INC | TRIMMED | −800 | 3.4K | −$66,884 | $351,122 |
| SCHBSCHWAB STRATEGIC TR | TRIMMED | −3.9K | 17.0K | −$202,277 | $813,268 |
| DFAIDIMENSIONAL ETF TRUST | ADDED | +6.5K | 47.8K | +$165,149 | $1M |
| TLTISHARES TR | ADDED | +1.5K | 11.6K | +$181,430 | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IVVISHARES TR | CORE S&P500 ETF · CORE S&P SCP ETF · CORE S&P MCP ETF · CORE US AGGBD ET · 20 YR TR BD ETF · EAFE SML CP ETF · RUS 1000 GRW ETF · RUS MD CP GR ETF · RUSSELL 2000 ETF | 51.07% | $69M | 277.3K |
| 2 | DFACDIMENSIONAL ETF TRUST | US CORE EQUITY 2 · US SMALL CAP VAL · INTL CORE EQUITY · INTL CORE EQT MK · EMGR CRE EQT MNG · EMERGING MKTS CO · US SMALL CAP ETF · US CORE EQT MKT · INTL SMALL CAP E | 14.46% | $20M | 765.8K |
| 3 | BRK/ABERKSHIRE HATHAWAY INC DEL | CL A · CL B NEW | 7.71% | $10M | 689 |
| 4 | VTIVANGUARD INDEX FDS | TOTAL STK MKT · SMALL CP ETF · MCAP GR IDXVIP · S&P 500 ETF SHS · SM CP VAL ETF | 7.42% | $10M | 49.3K |
| 5 | BNDVANGUARD BD INDEX FDS | TOTAL BND MRKT · INTERMED TERM | 5.49% | $7M | 99.5K |
| 6 | AAPLAPPLE INChistory → | COM | 2.27% | $3M | 18.7K |
| 7 | SPYSPDR S&P 500 ETF TRhistory → | TR UNIT | 1.99% | $3M | 6.6K |
| 8 | XPELXPEL INChistory → | COM | 1.32% | $2M | 26.3K |
| 9 | PRFINVESCO EXCHANGE TRADED FD Thistory → | FTSE RAFI 1000 | 1.30% | $2M | 11.2K |
| 10 | CLPTCLEARPOINT NEURO INChistory → | COM | 1.02% | $1M | 163.9K |
| 11 | SYKSTRYKER CORPORATION | COM | 0.97% | $1M | 4.6K |
| 12 | SPDR SER TR | PORTFOLI S&P1500 | 0.88% | $1M | 23.7K |
| 13 | SCHBSCHWAB STRATEGIC TR | US BRD MKT ETF | 0.60% | $813,268 | 17.0K |
| 14 | VEUVANGUARD INTL EQUITY INDEX F | ALLWRLD EX US · FTSE EMR MKT ETF | 0.57% | $765,965 | 15.6K |
| 15 | VEAVANGUARD TAX-MANAGED FDS | VAN FTSE DEV MKT | 0.56% | $755,727 | 16.7K |
| 16 | MAMASTERCARD INCORPORATED | CL A | 0.55% | $748,989 | 2.1K |
| 17 | VCSHVANGUARD SCOTTSDALE FDS | SHRT TRM CORP BD · LG-TERM COR BD | 0.51% | $686,414 | 8.9K |
| 18 | MRNAMODERNA INC | COM | 0.35% | $475,331 | 3.1K |
| 19 | AMZNAMAZON COM INC | COM | 0.26% | $351,122 | 3.4K |
| 20 | SRTSSENSUS HEALTHCARE INC | COM | 0.25% | $341,516 | 65.5K |
| 21 | VRNAVERONA PHARMA PLC | SPONSORED ADS | 0.18% | $241,864 | 12.0K |
| 22 | ZTSZOETIS INC | CL A | 0.18% | $240,791 | 1.4K |
| 23 | EXPION360 INC | COM | 0.10% | $134,417 | 27.8K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2025 | $196M | 49 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $196M | 49 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $194M | 50 | Nov 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $168M | 48 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $172M | 47 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $149M | 44 | Jan 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $130M | 47 | Oct 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $145M | 47 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $135M | 47 | May 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $138M | 47 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $112M | 41 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $118M | 41 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $135M | 41 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.